The European database of suspected drug reaction reports is EudraVigilance, which also tracks reports of injuries and deaths following the experimental COVID-19 “vaccines.” As high as these numbers are, they do NOT reflect all of Europe. The actual number in Europe who are reported dead or injured due to COVID-19 shots would be much higher.
The EudraVigilance database reports that through June 19, 2021 there are 15,472 deaths and 1,509,266 injuries reported following injections of four experimental COVID-19 shots:
- COVID-19 MRNA VACCINE PFIZER-BIONTECH
- https://dap.ema.europa.eu/analytics/saw.dll?PortalPages&PortalPath=%2Fshared%2FPHV%20DAP%2F_portal%2FDAP&Action=Navigate&P0=1&P1=eq&P2=%22Line%20Listing%20Objects%22.%22Substance%20High%20Level%20Code%22&P3=1+42325700
- COVID-19 VACCINE ASTRAZENECA (CHADOX1 NCOV-19)
Total reactions for the experimental mRNA vaccine Tozinameran (code BNT162b2,Comirnaty) from BioNTech/ Pfizer: 7,420 deaths and 560,256 injuries to 19/06/2021
- 16,133 Blood and lymphatic system disorders incl. 81 deaths
- 12,637 Cardiac disorders incl. 964 deaths
- 101 Congenital, familial and genetic disorders incl. 6 deaths
- 7000 Ear and labyrinth disorders incl. 4 deaths
- 265 Endocrine disorders incl. 1 death
- 8,122 Eye disorders incl. 17 deaths
- 51,030 Gastrointestinal disorders incl. 348 deaths
- 155,486 General disorders and administration site conditions incl. 2,290 deaths
- 468 Hepatobiliary disorders incl. 31 deaths
- 6,110 Immune system disorders incl. 32 deaths
- 17,549 Infections and infestations incl. 762 deaths
- 6,275 Injury, poisoning and procedural complications incl. 104 deaths
- 13,249 Investigations incl. 285 deaths
- 4,162 Metabolism and nutrition disorders incl. 139 deaths
- 79,125 Musculoskeletal and connective tissue disorders incl. 88 deaths
- 325 Neoplasms benign, malignant and unspecified (incl. cysts and polyps) incl. 23 deaths
- 100,895 Nervous system disorders incl. 780 deaths
- 384 Pregnancy, puerperium and perinatal conditions incl. 10 deaths
- 107 Product issues
- 9,928 Psychiatric disorders incl. 105 deaths
- 1,765 Renal and urinary disorders incl. 115 deaths
- 2,696 Reproductive system and breast disorders incl. 3 deaths
- 23,689 Respiratory, thoracic and mediastinal disorders incl. 848 deaths
- 26,641 Skin and subcutaneous tissue disorders incl. 66 deaths
- 846 Social circumstances incl. 10 deaths
- 281 Surgical and medical procedures incl. 19 deaths
- 14,987 Vascular disorders incl. 289 deaths
Total reactions for the experimental mRNA vaccine mRNA-1273(CX-024414) from Moderna: 4,147 deaths and 122,643 injuries to 19/06/2021
- 2,239 Blood and lymphatic system disorders incl. 29 deaths
- 3,315 Cardiac disorders incl. 446 deaths
- 39 Congenital, familial and genetic disorders incl. 3 deaths
- 1,454 Ear and labyrinth disorders
- 82 Endocrine disorders incl. 1 death
- 1,883 Eye disorders incl. 7 deaths
- 10,655 Gastrointestinal disorders incl. 142 deaths
- 33,936 General disorders and administration site conditions incl. 1,759 deaths
- 209 Hepatobiliary disorders incl. 11 deaths
- 1,117 Immune system disorders incl. 5 deaths
- 3,835 Infections and infestations incl. 234 deaths
- 2,480 Injury, poisoning and procedural complications incl. 77 deaths
- 2,670 Investigations incl. 89 deaths
- 1,297 Metabolism and nutrition disorders incl. 85 deaths
- 15,131 Musculoskeletal and connective tissue disorders incl. 77 deaths
- 128 Neoplasms benign, malignant and unspecified (incl. cysts and polyps) incl. 15 deaths
- 21,684 Nervous system disorders incl. 424 deaths
- 255 Pregnancy, puerperium and perinatal conditions incl. 2 death
- 20 Product issues
- 2,437 Psychiatric disorders incl. 69 deaths
- 807 Renal and urinary disorders incl. 52 deaths
- 459 Reproductive system and breast disorders incl. 1 death
- 5,640 Respiratory, thoracic and mediastinal disorders incl. 399 deaths
- 6,538 Skin and subcutaneous tissue disorders incl. 28 deaths
- 504 Social circumstances incl. 13 deaths
- 397 Surgical and medical procedures incl. 38 deaths
- 3,432 Vascular disorders incl. 141 deaths
Total reactions for the experimental vaccine AZD1222/VAXZEVRIA (CHADOX1 NCOV-19) from Oxford/ AstraZeneca: 3,364 deaths and 793,036 injuries to 19/06/2021
- 9,136 Blood and lymphatic system disorders incl. 132 deaths
- 12,135 Cardiac disorders incl. 396 deaths
- 95 Congenital, familial and genetic disorders incl. 2 deaths
- 8,797 Ear and labyrinth disorders
- 309 Endocrine disorders incl. 2 deaths
- 13,459 Eye disorders incl. 12 deaths
- 81,806 Gastrointestinal disorders incl. 161 deaths
- 212,663 General disorders and administration site conditions incl. 891 deaths
- 525 Hepatobiliary disorders incl. 25 deaths
- 3,085 Immune system disorders incl. 11 deaths
- 17,791 Infections and infestations incl. 217 deaths
- 7,854 Injury, poisoning and procedural complications incl. 77 deaths
- 16,731 Investigations incl. 79 deaths
- 9,765 Metabolism and nutrition disorders incl. 50 deaths
- 123,637 Musculoskeletal and connective tissue disorders incl. 45 deaths
- 332 Neoplasms benign, malignant and unspecified (incl. cysts and polyps) incl. 8 deaths
- 169,286 Nervous system disorders incl. 532 deaths
- 223 Pregnancy, puerperium and perinatal conditions incl. 4 deaths
- 103 Product issues
- 14,931 Psychiatric disorders incl. 27 deaths
- 2,809 Renal and urinary disorders incl. 29 deaths
- 5,967 Reproductive system and breast disorders
- 26,631 Respiratory, thoracic and mediastinal disorders incl. 387 deaths
- 36,457 Skin and subcutaneous tissue disorders incl. 22 deaths
- 772 Social circumstances incl. 4 deaths
- 671 Surgical and medical procedures incl. 16 deaths
- 17,066 Vascular disorders incl. 235 deaths
Total reactions for the experimental COVID-19 vaccine JANSSEN (AD26.COV2.S) from Johnson & Johnson: 541 deaths and 33, 331 injuries to 19/06/2021
- 306 Blood and lymphatic system disorders incl. 16 deaths
- 496 Cardiac disorders incl. 56 deaths
- 14 Congenital, familial and genetic disorders
- 177 Ear and labyrinth disorders
- 8 Endocrine disorders incl. 1 death
- 383 Eye disorders incl. 3 deaths
- 3,086 Gastrointestinal disorders incl. 23 deaths
- 8,761 General disorders and administration site conditions incl. 137 deaths
- 52 Hepatobiliary disorders incl. 4 deaths
- 85 Immune system disorders
- 392 Infections and infestations incl. 13 deaths
- 320 Injury, poisoning and procedural complications incl. 8 deaths
- 2,003 Investigations incl. 37 deaths
- 184 Metabolism and nutrition disorders incl. 10 deaths
- 5,718 Musculoskeletal and connective tissue disorders incl. 17 deaths
- 16 Neoplasms benign, malignant and unspecified (incl. cysts and polyps)
- 7,093 Nervous system disorders incl. 68 deaths
- 9 Pregnancy, puerperium and perinatal conditions incl. 1 death
- 9 Product issues
- 355 Psychiatric disorders incl. 5 deaths
- 119 Renal and urinary disorders incl. 8 deaths
- 114 Reproductive system and breast disorders
- 1,130 Respiratory, thoracic and mediastinal disorders incl. 43 deaths
- 804 Skin and subcutaneous tissue disorders incl. 2 deaths
- 72 Social circumstances incl. 3 deaths
- 336 Surgical and medical procedures incl. 26 deaths
- 1,289 Vascular disorders incl. 60 deaths
https://www.ema.europa.eu/en/human-regulatory/research-development/pharmacovigilance/eudravigilance/eudravigilance-system-overview
Post
Nessun commento:
Posta un commento